NCT01491100 (CogniPlus) is a clinical trial of Interferon beta-1b (Betaseron, BAY86-5046) in Multiple Sclerosis, sponsored by Bayer.

Who is sponsoring NCT01491100?

NCT01491100 is sponsored by Bayer.

What drugs are being tested in NCT01491100?

Interventions in NCT01491100: Interferon beta-1b (Betaseron, BAY86-5046).

What condition does NCT01491100 study?

NCT01491100 studies Multiple Sclerosis.

Is NCT01491100 still recruiting?

NCT01491100 is currently completed. Last updated 5 April 2018.

Last reviewed 2018-04-05 · How we verify

NCT01491100: CogniPlus

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Noninterventional Study Assessing Cognitive Function and Physical Activity in People With Multiple Sclerosis

Completed Last updated 5 April 2018

What this trial tests

trial testing Interferon beta-1b (Betaseron, BAY86-5046) in Multiple Sclerosis in 1,085 participants. Completed in 5 April 2017.

Timeline

30 April 2012

Primary endpoint
22 December 2016

5 April 2017

Quick facts

Lead sponsor	Bayer
Status	Completed
Study type	OBSERVATIONAL
Enrollment	1,085
Start date	30 April 2012
Primary completion	22 December 2016
Estimated completion	5 April 2017
Sites	17 locations across Tunisia, France, Netherlands, Greece, Turkey (Türkiye), Belgium, Kazakhstan, Saudi Arabia

Drugs / interventions tested

Interferon beta-1b (Betaseron, BAY86-5046) — full drug profile →

Conditions studied

Multiple Sclerosis — all drugs for Multiple Sclerosis →

Sponsor

Bayer — full company profile →

Who can join

Adults 12 to 70, any sex, with Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Study assessing cognitive function and physical activity in people with relapsing remitting multiple sclerosis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Interferon beta-1b (Betaseron, BAY86-5046)

Trials testing the same drug.

NCT02652091 — Impact of the BETACONNECT Auto-injector on BETASERON Therapy Adherence and Patient Satisfaction · completed
NCT00963833 — Study Evaluating Betaferons Safety and Tolerability In Pediatric Patients With Multiple Sclerosis · completed
NCT03408093 — Study of Betaferon Adherence in Patients With Multiple Sclerosis Treated With Interferon Beta-1b · completed

Other recruiting trials for Multiple Sclerosis

Currently open trials in the same condition.

NCT07507084 — The Effect of Internal- or External-Focused Exercise Training, Administered in Conjunction With a Cognitive Task, on Wal · NA · recruiting
NCT07524231 — Evaluation of the Effects of Laughter Yoga · NA · recruiting
NCT07489794 — URINARY INCONTINENCE AND PELVIC FLOOR MUSCLE ACTIVITY IN MULTIPLE SCLEROSIS · recruiting
NCT07236684 — Identification of Factors Related to UI in Patients With MS and EMG Assessment of PFM Activity · recruiting
NCT07500727 — Skeletal Muscle Aging and Responsiveness in Aged People With MS · NA · recruiting

Other Bayer trials

Trials by the same sponsor.

NCT05900388 — A Study to Observe the Pattern of Use and Safety of Rivaroxaban in Children Under 2 Years Old With Venous Thromboembolis · not yet recruiting
NCT07490431 — An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Sympt · not yet recruiting
NCT05477953 — An Observational Pregnancy Safety Study in Women Who Were Exposed to the Drug Nifurtimox During Pregnancy to Learn About · not yet recruiting
NCT07192952 — A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Child · Phase 3 · not yet recruiting
NCT07450599 — A Study to Learn How Well a Combination of Darolutamide and Androgen Deprivation Therapy (ADT) Works as a Treatment Befo · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01491100 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Bayer
Last refreshed: 5 April 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01491100.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing